PETMED EXPRESS, INC.

(PETS)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
21.78 USD   -0.77%
06/19PETMED EXPRESS : View the 2022 Proxy
PU
06/17PETMED EXPRESS : 2022 PetMed Express, Inc. Annual Report
PU
05/24PETMED EXPRESS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/17/2022 06/21/2022 06/22/2022 06/23/2022 06/24/2022 Date
20.65(c) 21.82(c) 21.41(c) 21.95(c) 21.78(c) Last
479 992 448 338 437 924 443 032 447 915 Volume
-0.34% +5.67% -1.88% +2.52% -0.77% Change
More quotes
Estimated financial data (e) (USD)
Sales 2023 286 M - -
Net income 2023 23,1 M - -
Net cash position 2023 112 M - -
P/E ratio 2023 19,2x
Yield 2023 6,11%
Sales 2024 299 M - -
Net income 2024 27,2 M - -
Net cash position 2024 108 M - -
P/E ratio 2024 16,4x
Yield 2024 6,70%
Capitalization 440 M 440 M -
EV / Sales 2023 1,15x
EV / Sales 2024 1,11x
Nbr of Employees 212
Free-Float 95,3%
More Financials
Company
PetMed Express, Inc. is a pet pharmacy, which is engaged in delivering prescription and non-prescription pet medications and other health products for dogs, cats and horses through its website at petmeds.com, as well as through its toll-free number. The Company's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. It offers various pet supplies, including food, beds,... 
Sector
Drug Retailers
Calendar
07/25Earnings Release
More about the company
Ratings of PetMed Express, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about PETMED EXPRESS, INC.
06/19PETMED EXPRESS : View the 2022 Proxy
PU
06/17PETMED EXPRESS : 2022 PetMed Express, Inc. Annual Report
PU
05/24PETMED EXPRESS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
05/19PETMED EXPRESS, INC. : Ex-dividend day for
FA
05/10PETMED EXPRESS INC : Results of Operations and Financial Condition, Regulation FD Disclosu..
AQ
05/10PETMED EXPRESS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
05/10Morgan Stanley Adjusts PetMed Express' Price Target to $20 from $21, Keeps Underweight ..
MT
05/09PETMED : Fiscal Q4 Earnings Snapshot
AQ
05/09TRANSCRIPT : PetMed Express, Inc., Q4 2022 Earnings Call, May 09, 2022
CI
05/09PetMed Express Reports Lower Fiscal Q4 Earnings, Sales
MT
05/09Earnings Flash (PETS) PETMED EXPRESS Posts Q4 EPS $0.30, vs. Street Est of $0.25
MT
05/09Earnings Flash (PETS) PETMED EXPRESS Posts Q4 Revenue $66M
MT
05/09PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declare..
GL
05/09PetMed Express, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022
CI
05/09PetMed Express, Inc. Declares Quarterly Dividend, Payable on May 27, 2022
CI
More news
News in other languages on PETMED EXPRESS, INC.
05/09PetMed Express annonce des revenus et des ventes inférieurs pour le quatrième trimestre..
05/09Earnings Flash (PETS) PETMED EXPRESS affiche un revenu de 66 millions de dollars au qua..
05/09PetMed Express, Inc. annonce ses résultats pour l'année complète se terminant le 31 mar..
05/09PetMed Express, Inc. Déclare un dividende trimestriel, payable le 27 mai 2022
05/09PetMed Express, Inc. annonce ses résultats pour le quatrième trimestre se terminant le ..
More news
Analyst Recommendations on PETMED EXPRESS, INC.
More recommendations
Chart PETMED EXPRESS, INC.
Duration : Period :
PetMed Express, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PETMED EXPRESS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 21,78 $
Average target price 24,00 $
Spread / Average Target 10,2%
EPS Revisions
Managers and Directors
Matthew N. Hulett President, Chief Executive Officer & Director
Bruce S. Rosenbloom Chief Financial Officer & Treasurer
Gian Mark Fulgoni Chairman
Mark Moseley Chief Technology & Information Officer
Ronald J. Korn Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PETMED EXPRESS, INC.-13.78%440
RAIA DROGASIL S.A.-19.09%6 256
AIN HOLDINGS INC.23.21%1 836
RITE AID CORPORATION-45.20%484
QOL HOLDINGS CO., LTD.-2.79%371
HLS THERAPEUTICS INC.-20.00%302